ArticleMolecular therapy. Oncology2026

mRNA CAR T cells promote tolerable, tunable therapy in preclinical high grade glioma models.

Monica Pomaville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.